108 related articles for article (PubMed ID: 26369313)
1. Diagnosis: A better FISH to detect pancreatobiliary cancer?
Patman G
Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):551. PubMed ID: 26369313
[No Abstract] [Full Text] [Related]
2. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
3. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
Zhai J
Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
[TBL] [Abstract][Full Text] [Related]
4. Beyond cytomorphology: expanding the diagnostic potential for biliary cytology.
Chadwick BE
Diagn Cytopathol; 2012 Jun; 40(6):536-41. PubMed ID: 22619128
[TBL] [Abstract][Full Text] [Related]
5. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.
Smoczynski M; Jablonska A; Matyskiel A; Lakomy J; Dubowik M; Marek I; Biernat W; Limon J
Gastrointest Endosc; 2012 Jan; 75(1):65-73. PubMed ID: 22078103
[TBL] [Abstract][Full Text] [Related]
6. Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.
Kipp BR; Barr Fritcher EG; Pettengill JE; Halling KC; Clayton AC
Cancer Cytopathol; 2013 Nov; 121(11):610-9. PubMed ID: 23633236
[TBL] [Abstract][Full Text] [Related]
7. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.
Barr Fritcher EG; Kipp BR; Halling KC; Clayton AC
Cytopathology; 2014 Oct; 25(5):288-301. PubMed ID: 25073411
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridisation in the cytological diagnosis of pancreatobiliary tumours.
Boldorini R; Paganotti A; Sartori M; Allegrini S; Miglio U; Orsello M; Veggiani C; Del Piano M; Monga G
Pathology; 2011 Jun; 43(4):335-9. PubMed ID: 21519286
[TBL] [Abstract][Full Text] [Related]
9. Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results.
Barr Fritcher EG; Caudill JL; Blue JE; Djuric K; Feipel L; Maritim BK; Ragheb AA; Halling KC; Henry MR; Clayton AC
Am J Clin Pathol; 2011 Sep; 136(3):442-9. PubMed ID: 21846921
[TBL] [Abstract][Full Text] [Related]
10. An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy.
Pu X; Zheng H; Yang X; Ye Q; Fan Z; Yang J; Fan X; Zhou X; Qiu Y; Huang Q; Wu H; Chen J
BMC Gastroenterol; 2020 Nov; 20(1):367. PubMed ID: 33148183
[TBL] [Abstract][Full Text] [Related]
11. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
12. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H
Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727
[TBL] [Abstract][Full Text] [Related]
13. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
[TBL] [Abstract][Full Text] [Related]
14. Isocitrate Dehydrogenase Genes.
Tsamaloukas A
Dtsch Arztebl Int; 2015 May; 112(21-22):372. PubMed ID: 26149376
[No Abstract] [Full Text] [Related]
15. Significance of mucin expression in pancreatobiliary neoplasms.
Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
[TBL] [Abstract][Full Text] [Related]
16. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
17. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
[TBL] [Abstract][Full Text] [Related]
18. Refined pancreatobiliary UroVysion criteria and an approach for further optimization.
Mettman D; Saeed A; Shold J; Laury R; Ly A; Khan I; Golem S; Olyaee M; O'Neil M
Cancer Med; 2021 Sep; 10(17):5725-5738. PubMed ID: 34374212
[TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Moreno Luna LE; Gores GJ
Liver Transpl; 2006 Nov; 12(11 Suppl 2):S15-9. PubMed ID: 17051561
[No Abstract] [Full Text] [Related]
20. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
Puik JR; Meijer LL; Le Large TY; Prado MM; Frampton AE; Kazemier G; Giovannetti E
Pharmacogenomics; 2017 Sep; 18(14):1343-1358. PubMed ID: 28832247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
